Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, Divi's Laboratories has informed that it enclosed the schedule of earnings conference call for the quarter ended June 30, 2026, to be held on August 01, 2026.
The above information is a part of company’s filings submitted to BSE.